Vermont Drug Litigation Lawyers

Bill Introduced To Bar Drug Firms From Pushing Authorized Generics

 In an effort to fight unfair practices by brand name drug manufacturers and provide consumers ongoing access to lower-priced generic drugs, Senators John D. (Jay) Rockefeller IV (D-WV), Charles Schumer (D-NY), and Patrick Leahy (D-VT) have introduced legislation to end the use of so-called “authorized generics” during the 180-day period that Congress intended for true generic market exclusivity.  Recent news reports have detailed how many brand name pharmaceutical companies game the system.  The legislation introduced, S. 3695, would provide real competition between generic companies producing low-cost medicines and the pharmaceutical giants.

“Authorized generics are a sham,” said Rockefeller.  “They are nothing more than repackaged prescription drugs without the benefit of a true generic’s lower cost.  This practice undermines congressional intent and harms consumers by preventing generic competition and eliminating billions of dollars in prescription drug savings over the long-term.”

“Authorized generics are wolves in sheep’s clothing, and when big drug companies push them onto the market, they undermine competition and raise prices for millions of Americans who struggle with high drug costs,” Schumer said. “When it comes to lowering drug prices, authorized generics are like a placebo – they don't do any good. We have seen an onslaught on generic drug makers that threatens to slam the door on cheaper alternatives to high-priced brand name drugs and authorized generics have been the weapon of choice.  At a time when drug prices continue to soar, authorized generics make it harder for those most in need.” Read more at leahy.senate.gov

Contact Vermont Drug Litigation Attorneys

Contact a Drug Litigation Lawyer now for a free case review.